Tandem Diabetes Care Inc (TNDM)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Tandem Diabetes Care Inc (TNDM) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011449
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tandem Diabetes Care Inc (Tandem) is a medical device company that designs, develops and manufactures diabetic care products. The company offers products which include t:slim X2 insulin pump, t:slim G4 insulin pump, t:flex insulin pump, t:simulator demo app, software and apps, t:connect application and tandem device updater. It utilizes micro-delivery and color touchscreen technologies. Tandem also offers infusion set, which is a 90° flexible soft cannula. The company offers a wide range of accessories and supplies to help its clients to further customize their systems. It markets its products through its distribution network. Tandem is headquartered in San Diego, California, the US.

Tandem Diabetes Care Inc (TNDM) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Tandem Diabetes Care Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Tandem Diabetes Care Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Tandem Diabetes Care Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Tandem Diabetes Care Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Tandem Diabetes Care Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Tandem Diabetes Care Inc, Medical Equipment, Deal Details 11
Asset Purchase 11
Tandem Diabetes Care Acquires US Patents And Patent Applications From Smiths Medical 11
Venture Financing 12
Tandem Diabetes Care Raises US$36.4 Million In Series D Financing 12
Tandem Diabetes Care Secures US$12 Million In Financing 13
Partnerships 14
Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies 14
Tandem Expands Licensing Agreement With Dexcom For Glucose Monitoring System 15
Tandem Diabetes Enters Into Licensing Agreement With DexCom 16
Tandem Diabetes Care Enters into Co-Development Agreement with Dexcom 17
Tandem Diabetes Enters Into Co-Development Agreement With JDRF For Dual-Chamber Infusion Pump 18
Equity Offering 19
Tandem Diabetes Care Plans to Raise USD10.7 Million in Public Offering of Securities 19
Tandem Diabetes Care Prices Public Offering of Shares for USD16.2 Million 20
Tandem Diabetes Care Plans to Raise up to USD15 Million in Public Offering of Shares 22
Tandem Diabetes Care Raises USD23 Million in Public Offering of Shares 23
Tandem Diabetes Raises USD69.4 Million in Public Offering of Shares 25
Tandem Diabetes Care Completes IPO For US$138 Million 27
Tandem Diabetes Care Inc – Key Competitors 29
Tandem Diabetes Care Inc – Key Employees 30
Tandem Diabetes Care Inc – Locations And Subsidiaries 31
Head Office 31
Recent Developments 32
Financial Announcements 32
Jul 27, 2017: Tandem Diabetes Care Reports Second Quarter 2017 Financial Results 32
Apr 27, 2017: Tandem Diabetes Care Reports First Quarter 2017 Financial Results 34
Mar 08, 2017: Tandem Diabetes Care Reports 2016 Financial Results 36
Nov 01, 2016: Tandem Diabetes Care Reports Third Quarter 2016 Financial Results 38
Apr 28, 2016: Tandem Diabetes Care Reports First Quarter 2016 Financial Results and Updates 2016 Guidance 40
Feb 24, 2016: Tandem Diabetes Care Reports Fourth Quarter and Full Year 2015 Financial Results 41
Corporate Communications 42
Dec 07, 2017: Tandem Diabetes Care CFO to Retire, Successor Named 42
Apr 08, 2016: Dr. Henry Anhalt to Step Down From Tandem Diabetes Care Board of Directors to Ensure No Risk of Potential Conflict of Interest 43
Mar 14, 2016: Tandem Diabetes Care Announces Appointment of Dr. Henry Anhalt as Board Member 44
Feb 02, 2016: Tandem Diabetes Care Expands Commercial Leadership 45
Product News 46
Dec 14, 2017: Tandem Diabetes Care Announces Issuance of Patent Related to Automated Insulin Delivery Technology 46
Aug 24, 2017: Tandem Diabetes Care Announces Issuance of Patent Related to Remote Bolus Feature for Medical Infusion Pumps 47
Aug 08, 2017: Tandem Diabetes Care Announces Issuance of Patent Related to Important Safety Features for Portable Infusion Pumps that Utilize Touchscreen Control 48
Feb 15, 2017: Data Presented at ATTD 2017 Demonstrate Clinical Advantages of Tandem Diabetes Care Sensor-augmented Pump over Medtronic MiniMed SAPs 49
Other Significant Developments 50
Jul 28, 2016: Tandem Diabetes Care Reports Second Quarter 2016 Financial Results 50
Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51

List of Tables
Tandem Diabetes Care Inc, Medical Equipment, Key Facts, 2016 2
Tandem Diabetes Care Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Tandem Diabetes Care Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Tandem Diabetes Care Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Tandem Diabetes Care Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Tandem Diabetes Care Inc, Deals By Market, 2011 to YTD 2017 9
Tandem Diabetes Care Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Tandem Diabetes Care Acquires US Patents And Patent Applications From Smiths Medical 11
Tandem Diabetes Care Raises US$36.4 Million In Series D Financing 12
Tandem Diabetes Care Secures US$12 Million In Financing 13
Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies 14
Tandem Expands Licensing Agreement With Dexcom For Glucose Monitoring System 15
Tandem Diabetes Enters Into Licensing Agreement With DexCom 16
Tandem Diabetes Care Enters into Co-Development Agreement with Dexcom 17
Tandem Diabetes Enters Into Co-Development Agreement With JDRF For Dual-Chamber Infusion Pump 18
Tandem Diabetes Care Plans to Raise USD10.7 Million in Public Offering of Securities 19
Tandem Diabetes Care Prices Public Offering of Shares for USD16.2 Million 20
Tandem Diabetes Care Plans to Raise up to USD15 Million in Public Offering of Shares 22
Tandem Diabetes Care Raises USD23 Million in Public Offering of Shares 23
Tandem Diabetes Raises USD69.4 Million in Public Offering of Shares 25
Tandem Diabetes Care Completes IPO For US$138 Million 27
Tandem Diabetes Care Inc, Key Competitors 29
Tandem Diabetes Care Inc, Key Employees 30

★海外企業調査レポート[Tandem Diabetes Care Inc (TNDM)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Northern Oil & Gas Inc (NOG):企業の財務・戦略的SWOT分析
    Summary Northern Oil & Gas Inc (Northern) is an oil and gas company that offers acquisition, exploration and production services. The company acquires and maintains oil and natural gas properties in Bakken and Three Forks formations within the Williston Basin in North Dakota and Montana. It offers s …
  • Ventas Inc:企業のM&A・事業提携・投資動向
    Ventas Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ventas Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Taiho Pharmaceutical Co Ltd:企業の戦略的SWOT分析
    Taiho Pharmaceutical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Atlantic Power Corporation:企業の発電所・SWOT分析2018
    Atlantic Power Corporation - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …
  • Ajinomoto Co Inc (2802):企業の財務・戦略的SWOT分析
    Ajinomoto Co Inc (2802) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Genedata AG-製薬・医療分野:企業M&A・提携分析
    Summary Genedata AG (Genedata) is a healthcare technology company that transforms data into software solutions. The company delivers enterprise solutions for data analytics that streamline research and development workflows and improve research productivity. Its products include genedata biologics, …
  • Ryanair Holdings plc (RY4C):企業の財務・戦略的SWOT分析
    Ryanair Holdings plc (RY4C) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Parker Drilling Co (PKD):企業の財務・戦略的SWOT分析
    Parker Drilling Co (PKD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sinochem Group:企業の戦略・SWOT・財務分析
    Sinochem Group - Strategy, SWOT and Corporate Finance Report Summary Sinochem Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Albemarle Corporation:戦略・SWOT・企業財務分析
    Albemarle Corporation - Strategy, SWOT and Corporate Finance Report Summary Albemarle Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Grainger Plc (GRI):企業の財務・戦略的SWOT分析
    Grainger Plc (GRI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Gooch & Housego PLC:企業の戦略・SWOT・財務情報
    Gooch & Housego PLC - Strategy, SWOT and Corporate Finance Report Summary Gooch & Housego PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Datang International Power Generation Co Ltd (991):電力:M&Aディール及び事業提携情報
    Summary Datang International Power Generation Company Limited (Datang Power), a subsidiary of China Datang Corporation, is an independent power generation company. It develops power plants; produces and distributes electricity; and sells heat. The company generates electricity from coal-fired genera …
  • Protective Life Corporation:企業の戦略・SWOT・財務情報
    Protective Life Corporation - Strategy, SWOT and Corporate Finance Report Summary Protective Life Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Britannia Industries Ltd (BRITANNIA):企業の財務・戦略的SWOT分析
    Britannia Industries Ltd (BRITANNIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • South Egypt Drug Industries Co:企業の戦略的SWOT分析
    South Egypt Drug Industries Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • AMAG Pharmaceuticals Inc (AMAG)-医療機器分野:企業M&A・提携分析
    Summary AMAG Pharmaceuticals Inc (AMAG) is a biopharmaceutical company that develops and commercializes specialty pharmaceutical products. The company focuses on maternal health, anemia management and cancer supportive care. Its major products include Makena (hydroxyprogesterone caproate injection) …
  • Adaptimmune Therapeutics Plc (ADAP):製薬・医療:M&Aディール及び事業提携情報
    Summary Adaptimmune Therapeutics Plc (Adaptimmune), formerly Adaptimmune Therapeutics Limited, is a clinical stage biopharmaceutical company that develops innovative T-cell therapy products for the treatment of cancer. It harnesses the proprietary SPEAR (Specific Peptide Enhanced Affinity Receptor) …
  • Tempur Sealy International Inc (TPX):企業の財務・戦略的SWOT分析
    Tempur Sealy International Inc (TPX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Uber Technologies Inc:企業の戦略・SWOT・財務情報
    Uber Technologies Inc - Strategy, SWOT and Corporate Finance Report Summary Uber Technologies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆